Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
IT0004147952
Thu, 09.01.2025
Newron Pharmaceuticals S.p.A.
Newron and Myung In Pharm announce license agreementfor evenamide in South Korea
Myung In Pharm to develop, manufacture and commercialize evenamide in South Korea
Myung In Pharm to contribute 10% of patients to Newron’s pivotal Phase III trial for evenamide, and share global development costs
Newron will receive upfront payment, development and [ … ]